EUCTR2006-003173-27-IT进行中（未招募）不适用
A Multi-Center, Single Arm Study Evaluating De Novo Once Monthly Darbepoetin Alfa Dosing for the Correction of Anemia in Subjects with Chronic Kidney Disease Not Receiving Dialysis - Darbepoetin Alfa 20060163
AMGEN S.P.A.0 个研究点目标入组 155 人开始时间: 2006年12月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 155
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •8805; 18 years of age Estimated Glomerular Filtration Rate eGFR of 8805; 15 mL/min/1.73 m2 - 8804; 60 mL/min/1.73 m2 MDRD equation The mean of two screening Hb values taken at least 7 days apart must be 11.0 g/dL Serum Ferritin 8805; 100 g/L
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Upper or lower GI bleeding within the prior 6 months ESA use within 12 weeks before enrollment Uncontrolled hypertension Other hematologic disorders Prior history within 12 weeks before enrollment of events including o Acute myocardial ischemia o Hospitalization for congestive heart failure o Myocardial infarction o Deep vein thrombosis, stroke or transient ischemic attack
研究者
相似试验
进行中（未招募）
1 期
A Multi-Center, Single Arm Study Evaluating De Novo Once Monthly (QM) Darbepoetin Alfa Dosing for the Correction of Anemia in Subjects with Chronic Kidney Disease (CKD) Not Receiving DialysisAnemia in subjects with chronic kidney disease not receiving dialysisEUCTR2006-003173-27-FRAmgen Limited155
进行中（未招募）
不适用
A Multi-Center, Single Arm Study Evaluating De Novo Once Monthly (QM) Darbepoetin Alfa Dosing for the Correction of Anemia in Subjects with Chronic Kidney Disease (CKD) Not Receiving DialysisEUCTR2006-003173-27-ATAmgen Limited155
尚未招募
Unknown
A multi-center, single-arm clinical study for the efficacy and safety of '10THERMA' on tissue coagulation and skin rejuvenatioFactors influencing health status and contact with health servicesKCT0008709Korean Society for Laser Medicine and Sugery31
招募中
1 期
To evaluate the safety tolerability and performance of the liver assist device (EBDLR System) in patients suffering from Acute Liver FailureCTRI/2024/02/062612Ykrita Life sciences Pvt Ltd.
进行中（未招募）
不适用
Multi-centre, phase II, single arm study of the docetaxel, oxaliplatin, capecitabine (DOC) combination in untreated patients with advanced or metastatic gastric cancerEUCTR2011-001720-37-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO